Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Sale of 1,911 MGX shares, $2.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 1,911 | $2.2K |
| Jun 10, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 2,884 | $3.7K |
| Apr 3, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Grant/Award | 24,000 | n/a |
| Mar 9, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 1,581 | $2.5K |
| Dec 8, 2025 | Metagenomi, Inc. (MGX) | Sale | 1,576 | $2.8K |
| Dec 2, 2025 | Metagenomi, Inc. (MGX) | Sale | 1,576 | $2.9K |
| Jun 9, 2025 | Metagenomi, Inc. (MGX) | Sale | 1,576 | $2.8K |
| Apr 3, 2025 | Metagenomi, Inc. (MGX) | Grant/Award | 14,000 | n/a |
| Mar 7, 2025 | Metagenomi, Inc. (MGX) | Sale | 1,808 | $3.4K |
| Dec 6, 2024 | Metagenomi, Inc. (MGX) | Sale | 1,559 | $2.9K |